305 related articles for article (PubMed ID: 30146487)
1. Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo.
Courtney KD; Bezwada D; Mashimo T; Pichumani K; Vemireddy V; Funk AM; Wimberly J; McNeil SS; Kapur P; Lotan Y; Margulis V; Cadeddu JA; Pedrosa I; DeBerardinis RJ; Malloy CR; Bachoo RM; Maher EA
Cell Metab; 2018 Nov; 28(5):793-800.e2. PubMed ID: 30146487
[TBL] [Abstract][Full Text] [Related]
2. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
3. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract][Full Text] [Related]
4. SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis.
Ma Y; Qi Y; Wang L; Zheng Z; Zhang Y; Zheng J
Free Radic Biol Med; 2019 Apr; 134():458-467. PubMed ID: 30703481
[TBL] [Abstract][Full Text] [Related]
5. Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma.
Minton DR; Fu L; Chen Q; Robinson BD; Gross SS; Nanus DM; Gudas LJ
PLoS One; 2015; 10(4):e0120649. PubMed ID: 25830305
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide-dependent kinase 1-associated glycolysis is regulated by miR-409-3p in clear cell renal cell carcinoma.
Wang Y; He Y; Bai H; Dang Y; Gao J; Lv P
J Cell Biochem; 2019 Jan; 120(1):126-134. PubMed ID: 30218446
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial metabolism in primary and metastatic human kidney cancers.
Bezwada D; Lesner NP; Brooks B; Vu HS; Wu Z; Cai L; Kasitinon S; Kelekar S; Cai F; Aurora AB; Patrick M; Leach A; Ghandour R; Zhang Y; Do D; Sudderth J; Dumesnil D; House S; Rosales T; Poole AM; Lotan Y; Woldu S; Bagrodia A; Meng X; Cadeddu JA; Mishra P; Pedrosa I; Kapur P; Courtney KD; Malloy CR; Margulis V; DeBerardinis RJ
bioRxiv; 2023 Feb; ():. PubMed ID: 36798172
[TBL] [Abstract][Full Text] [Related]
8. A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer.
Yang Y; Valera V; Sourbier C; Vocke CD; Wei M; Pike L; Huang Y; Merino MA; Bratslavsky G; Wu M; Ricketts CJ; Linehan WM
Cancer Genet; 2012; 205(7-8):377-90. PubMed ID: 22867999
[TBL] [Abstract][Full Text] [Related]
9. Isotopomer analyses with the tricarboxylic acid cycle intermediates and exchanging metabolites from the rat kidney.
Jin ES; Wen X; Malloy CR
NMR Biomed; 2023 Oct; 36(10):e4994. PubMed ID: 37392148
[TBL] [Abstract][Full Text] [Related]
10. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
[TBL] [Abstract][Full Text] [Related]
11. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of [U-13 C]glucose in human brain tumors in vivo.
Maher EA; Marin-Valencia I; Bachoo RM; Mashimo T; Raisanen J; Hatanpaa KJ; Jindal A; Jeffrey FM; Choi C; Madden C; Mathews D; Pascual JM; Mickey BE; Malloy CR; DeBerardinis RJ
NMR Biomed; 2012 Nov; 25(11):1234-44. PubMed ID: 22419606
[TBL] [Abstract][Full Text] [Related]
13. Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors.
Marin-Valencia I; Cho SK; Rakheja D; Hatanpaa KJ; Kapur P; Mashimo T; Jindal A; Vemireddy V; Good LB; Raisanen J; Sun X; Mickey B; Choi C; Takahashi M; Togao O; Pascual JM; Deberardinis RJ; Maher EA; Malloy CR; Bachoo RM
NMR Biomed; 2012 Oct; 25(10):1177-86. PubMed ID: 22383401
[TBL] [Abstract][Full Text] [Related]
14. Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies.
Johnston K; Pachnis P; Tasdogan A; Faubert B; Zacharias LG; Vu HS; Rodgers-Augustyniak L; Johnson A; Huang F; Ricciardo S; Zhao Z; Mathews TP; Watt T; Leavey P; DeBerardinis RJ
Med; 2021 Apr; 2(4):395-410. PubMed ID: 33860280
[TBL] [Abstract][Full Text] [Related]
15. MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma.
Neumann CKA; Silver DJ; Venkateshwari V; Zhang R; Traughber CA; Przybycin C; Bayik D; Smith JD; Lathia JD; Rini BI; Brown JM
Mol Metab; 2020 Apr; 34():136-145. PubMed ID: 32180553
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target.
Gerlinger M; Santos CR; Spencer-Dene B; Martinez P; Endesfelder D; Burrell RA; Vetter M; Jiang M; Saunders RE; Kelly G; Dykema K; Rioux-Leclercq N; Stamp G; Patard JJ; Larkin J; Howell M; Swanton C
J Pathol; 2012 Jun; 227(2):146-56. PubMed ID: 22362593
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A virus cellular receptor 1/kidney injury molecule-1 is a susceptibility gene for clear cell renal cell carcinoma and hepatitis A virus cellular receptor/kidney injury molecule-1 ectodomain shedding a predictive biomarker of tumour progression.
Cuadros T; Trilla E; Vilà MR; de Torres I; Vilardell J; Messaoud NB; Salcedo M; Sarró E; López-Hellin J; Blanco A; Mir C; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
Eur J Cancer; 2013 May; 49(8):2034-47. PubMed ID: 23352434
[TBL] [Abstract][Full Text] [Related]
19.
Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
[TBL] [Abstract][Full Text] [Related]
20. Expression of PGAM1 in renal clear cell carcinoma and its clinical significance.
Li C; Shu F; Lei B; Lv D; Zhang S; Mao X
Int J Clin Exp Pathol; 2015; 8(8):9410-5. PubMed ID: 26464696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
